Mandate

VINGE ADVISES LATOUR

November 12, 2015

Vinge has advised Latour in connection with the sale of Specma AB to Hydra-Grene, a wholly-owned subsidiary of the Danish industrial conglomerate, Schouw & Co. The transaction is conditional upon approval by the relevant competition authorities and is estimated to be completed by the end of 2015.

Vinge’s team primarily consisted of Magnus Pauli, Johanna Björnum Nyström and Daniel Lennartsson.

Related

Vinge has advised Vimian Group AB in connection with its uplisting to Nasdaq Stockholm

Vinge has advised Vimian Group AB (publ) in connection with its list change from Nasdaq First North Growth Market to Nasdaq Stockholm’s main market, Large cap. The prospectus was published on 21 March 2025 and the trading on Nasdaq Stockholm commenced on 28 March 2025.
March 28, 2025

Vinge advises Tribune Therapeutics in conjunction with financing round

Vinge advises Tribune Therapeutics, a Swedish biotechnology company focused on developing therapies for fibrotic diseases, in raising 23 MEUR. The financing round includes the previous investors HealthCap, Novo Holding and Innovestor, in addition to the new investors LifeArc Ventures, Industrifonden and Investinor.
March 26, 2025

Vinge advises Dignitana on the public offer from Paxman

Paxman AB (publ) has announced a public offer to the shareholders of Dignitana AB. The total value of the offer is approximately SEK 153 million.
March 24, 2025